Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Statement of Cash Flows [Abstract]    
Net loss $ (1,412,070) $ (1,589,432)
Adjustments to reconcile net loss to net cash used in operating activities:    
Gain on forgiveness of PPP loan (279,191)
Change in inventory value 156,600
Stock-based compensation 336,293 906,919
Bad debt expense 64,000 78,125
Changes in operating assets and liabilities:    
Accounts receivable (50,650) 154,840
Prepaid expenses and other assets 10,147 (59,086)
Accounts payable and accrued liabilities 538,998 371,076
Deferred revenue (188,000) (174,250)
Net cash provided by (used in) operating activities (701,282) (434,399)
Net cash used in investing activities
Cash flows from financing activities:    
Proceeds from the sale of common stock 572,906 725,050
Payments of notes payable (47,847)
Payments of shareholder advance (24,283)
Proceeds from advances - related party 183,558
Payments of advances - related party (160,085)
Net cash provided by financing activities 524,249 725,050
Net increase (decrease) in cash (177,033) 290,651
Cash, beginning of period 249,462 71,075
Cash, end of period 72,429 361,726
Supplemental disclosures of cash flow information:    
Cash paid for interest 5,932
Cash paid for income taxes
Non-cash investing and financing activities:    
Commitment shares issued in conjunction with capital raise 200,000
Shares issued for vested restricted stock units 242 108
Shares issued for settlement of class action 1,941
Shares issued for cashless exercise of warrants $ 229